Clinical Trial: A Mediterranean Low-FODMAP Diet Alleviates Symptoms of Non-Constipation IBS—Randomized Controlled Study and Volatomics Analysis
Nutrients · 2025
DOI: 10.3390/nu17091545 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Arezina N Kasti und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Dietetics, Attikon University General Hospital, 12462 Athens, Greece. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Diet, Mediterranean, Diet, Carbohydrate-Restricted. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Approximately 20% of patients with irritable bowel syndrome (IBS) link symptoms to food intake; a low-FODMAP diet is effective in managing these symptoms.
Aims
To evaluate the effectiveness of the Mediterranean version of the low-FODMAP Diet (MED–LFD) compared to NICE guidelines for IBS and to assess changes in stool volatile compound levels.
Methods
108 patients with Rome IV IBS without constipation were randomized into the MED–LFD or NICE group. Primary endpoints included changes in symptom severity and responder rate (reduction of >50 IBS-SSS points) after intervention and at 6 months. Secondary endpoints assessed quality of life, symptom burden, adequate relief, anxiety/depression levels, and adherence. Volatile compound levels were measured using Gas Chromatography/Mass Spectrometry.
Results
At both time points, the MED–LFD group showed a significantly greater improvement in symptom severity (159 ± 80 vs. 253 ± 94 and 168 ± 117 vs. 245 ± 98), responder rates (84.6% vs. 60.8% and 79.1% vs. 52.3%), and adherence (75% vs. 41% and 45% vs. 7%). Similar results were observed for all secondary endpoints, with no serious adverse events reported. The MED–LFD intervention was the strongest independent predictor of being a responder at the first (OR = 6.66; 95%CI = 1.46, 30.4) and second follow-up (OR = 4.85; 95%CI = 1.31, 17.96). Short and branched-chain fatty acids were significantly reduced at both follow-ups.
Conclusions
The MED–LFD is superior to NICE recommendations in managing non-constipated IBS symptoms and quality of life. It remains to be proven that reduced volatile compound levels might be an objective marker of response to dietary interventions. ClinicalTrials.gov ID: NCT03997708.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Dietetics, Attikon University General Hospital, 12462 Athens, Greece.
- Department of Food Science and Technology, University of Peloponnese, 24100 Kalamata, Greece.
- 4th Department of Internal Medicine, Medical School, Attikon University General Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece.
- Department of Clinical Nutrition and Dietetics, General Hospital of Karpathos "Aghios Ioannis Karpathios", 85700 Karpathos, Greece.
- Department of Nutrition and Dietetics Sciences, Hellenic Mediterranean University, 72300 Sitia, Greece.
- Hepatogastroenterology Unit, 2nd Propaedeutic Department of Internal Medicine, Medical School, Attikon University General Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece.
ORCID-Profile: Arezina N Kasti, Konstantinos Katsas, Dimitrios E Pavlidis, Emmanouil Stylianakis, Konstantinos I Petsis, Sophia Lambrinou, Maroulla D Nikolaki, Ioannis S Papanikolaou, Konstantinos Papadimitriou, Jane G Muir, Konstantinos Triantafyllou
Zitieren
APA
Kasti, A. N., Katsas, K., Pavlidis, D. E., Stylianakis, E., Petsis, K. I., Lambrinou, S., Nikolaki, M. D., Papanikolaou, I. S., Hatziagelaki, E., Papadimitriou, K., Kapolos, J., Muir, J. G., & Triantafyllou, K. (2025). Clinical Trial: A Mediterranean Low-FODMAP Diet Alleviates Symptoms of Non-Constipation IBS—Randomized Controlled Study and Volatomics Analysis. Nutrients. https://doi.org/10.3390/nu17091545
Vancouver
Kasti AN, Katsas K, Pavlidis DE, Stylianakis E, Petsis KI, Lambrinou S, et al. Clinical Trial: A Mediterranean Low-FODMAP Diet Alleviates Symptoms of Non-Constipation IBS—Randomized Controlled Study and Volatomics Analysis. Nutrients. 2025. doi:10.3390/nu17091545
BibTeX
@article{Kasti2025,
author = {Kasti, Arezina N and Katsas, Konstantinos and Pavlidis, Dimitrios E and Stylianakis, Emmanouil and Petsis, Konstantinos I and Lambrinou, Sophia and Nikolaki, Maroulla D and Papanikolaou, Ioannis S and Hatziagelaki, Erifili and Papadimitriou, Konstantinos and Kapolos, John and Muir, Jane G and Triantafyllou, Konstantinos},
title = {Clinical Trial: A Mediterranean Low-FODMAP Diet Alleviates Symptoms of Non-Constipation IBS—Randomized Controlled Study and Volatomics Analysis},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17091545}
}
EUVIMED